Delivery Order SPE2DB20D1004-SPE2DB24FG6R0
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,397.99, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,476.62, is for the delivery of OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,691.83 firm fixed-price order is for OLUMIANT 2 MG TABLET 30S, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OLUMIANT 2 MG TABLET 30S. The contract has a ceiling value of $30,262.56 and is a firm fixed-price delivery order. The ultimate completion date is May 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,962.58 and a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, and it is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,272.35 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $19,019.85, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, with a period of performance through June 16, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,633.37 firm fixed-price delivery order is for OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,098.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565393817 OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 9, 2024 and is not a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a $26,609.42 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of 4,565,698,957 units of the prescription medication OLUMIANT 2 MG TABLET 30S. The delivery order has a firm fixed price structure and a completion date of September 6, 2024. This contract is not set aside for any specific business type. Amerisourcebergen has been awarded...